S15-050 Mobilizing anti-tumor immunity by targeting chemerin receptor CCRL2 Researchers at Stanford have developed a new, patented strategy to enhance anti-tumor immune responses to treat cancer. Cancer is the second leading cause of death in the United States and inflicts a tremendous burden on public health. Justin Monnier Alexander Scholz Eugene Butcher Brian Zabel Russell Pachynski